These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 7582456)
1. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS). Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456 [TBL] [Abstract][Full Text] [Related]
2. Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF. Häfner D; Germann PG; Hauschke D Pulm Pharmacol; 1994 Oct; 7(5):319-32. PubMed ID: 7626919 [TBL] [Abstract][Full Text] [Related]
3. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome. Häfner D; Germann PG; Hauschke D Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777 [TBL] [Abstract][Full Text] [Related]
4. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant. Häfner D; Germann PG J Pharmacol Toxicol Methods; 1999; 41(2-3):97-106. PubMed ID: 10598681 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone enhances the activity of rSP-C surfactant but not of exosurf in a rat model of the acute lung injury. Häfner D; Germann PG J Pharmacol Toxicol Methods; 1999 Sep; 42(1):39-48. PubMed ID: 10715602 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations. Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964 [TBL] [Abstract][Full Text] [Related]
7. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country. da Costa DE; Pai MG; Al Khusaiby SM Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709 [TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity. Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532 [TBL] [Abstract][Full Text] [Related]
9. Exogenous surfactants in a piglet model of acute respiratory distress syndrome. Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138 [TBL] [Abstract][Full Text] [Related]
10. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf). Pfenninger J; Aebi C; Bachmann D; Wagner BP Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337 [TBL] [Abstract][Full Text] [Related]
11. Improvement of lung mechanics by exogenous surfactant: effect of prior application of high positive end-expiratory pressure. Hartog A; Gommers D; Haitsma JJ; Lachmann B Br J Anaesth; 2000 Nov; 85(5):752-6. PubMed ID: 11094593 [TBL] [Abstract][Full Text] [Related]
12. Treatment of ventilation-induced lung injury with exogenous surfactant. Vazquez de Anda GF; Lachmann RA; Gommers D; Verbrugge SJ; Haitsma J; Lachmann B Intensive Care Med; 2001 Mar; 27(3):559-65. PubMed ID: 11355126 [TBL] [Abstract][Full Text] [Related]
13. A rat model of acute respiratory distress syndrome (ARDS): Part 1. Time dependency of histological and pathological changes. Germann PG; Häfner D J Pharmacol Toxicol Methods; 1998 Aug; 40(2):101-7. PubMed ID: 10100499 [TBL] [Abstract][Full Text] [Related]
14. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. Balaraman V; Meister J; Ku TL; Sood SL; Tam E; Killeen J; Uyehara CF; Egan E; Easa D Am J Respir Crit Care Med; 1998 Jul; 158(1):12-7. PubMed ID: 9655700 [TBL] [Abstract][Full Text] [Related]
15. Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome. Billman D; Nicks J; Schumacher R Pediatr Pulmonol; 1994 Nov; 18(5):279-83. PubMed ID: 7898965 [TBL] [Abstract][Full Text] [Related]
16. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant. Hamdan AH; Shaw NJ Pediatr Pulmonol; 1998 Mar; 25(3):191-5. PubMed ID: 9556011 [TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network. Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199 [TBL] [Abstract][Full Text] [Related]
19. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I. Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938 [TBL] [Abstract][Full Text] [Related]
20. Physiologic response and lung distribution of lavage versus bolus Exosurf in piglets with acute lung injury. Balaraman V; Sood SL; Finn KC; Hashiro G; Uyehara CF; Easa D Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1838-43. PubMed ID: 8665043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]